NCT02702817View on ClinicalTrials.gov

Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia

PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

August 1, 2012

Primary Completion Date

March 31, 2017

Study Completion Date

July 15, 2017

Conditions
Alzheimer DiseaseCognitive Decline Due to Alzheimer DiseaseMild Cognitive Impairment Due to Alzheimer Disease
Interventions
DRUG

Naproxen

pale blue oval tablets

DRUG

Placebo

pale blue oval tablets with no active ingredients, identical in appearance to naproxen intervention

Trial Locations (1)

H4H1R3

Douglas Hospital Research Centre, Montreal

All Listed Sponsors
collaborator

McGill University

OTHER

collaborator

Johns Hopkins University

OTHER

lead

Douglas Mental Health University Institute

OTHER

NCT02702817 - Randomized Trial of Low-dose Naproxen in Cognitively Intact Persons at Risk of Alzheimer's Dementia | Biotech Hunter | Biotech Hunter